Biomaterials

• 

  Publication Venue For

  • Electrodeposited platinum-iridium coating improves in vivo recording performance of chronically implanted microelectrode arrays..  205:120-132. 2019
  • Long circulating genetically encoded intrinsically disordered zwitterionic polypeptides for drug delivery..  192:475-485. 2019
  • Porous PEEK improves the bone-implant interface compared to plasma-sprayed titanium coating on PEEK..  185:106-116. 2018
  • Metabolic glycan labeling and chemoselective functionalization of native biomaterials..  182:127-134. 2018
  • Anti-infective biomaterials with surface-decorated tachyplesin I..  178:351-362. 2018
  • Engineered cardiac tissue patch maintains structural and electrical properties after epicardial implantation..  159:48-58. 2018
  • Active immunotherapy for TNF-mediated inflammation using self-assembled peptide nanofibers..  149:1-11. 2017
  • Enrichment of endogenous fractalkine and anti-inflammatory cells via aptamer-functionalized hydrogels..  142:52-61. 2017
  • Change in surface roughness by dynamic shape-memory acrylate networks enhances osteoblast differentiation..  110:34-44. 2016
  • Dynamic culture yields engineered myocardium with near-adult functional output..  111:66-79. 2016
  • Systematic optimization of an engineered hydrogel allows for selective control of human neural stem cell survival and differentiation after transplantation in the stroke brain..  105:145-155. 2016
  • Controlling the kinetics of thiol-maleimide Michael-type addition gelation kinetics for the generation of homogenous poly(ethylene glycol) hydrogels..  101:199-206. 2016
  • Elastic hydrogel as a sensor for detection of mechanical stress generated by single cells grown in three-dimensional environment..  98:103-112. 2016
  • Transdifferentiation of human endothelial progenitors into smooth muscle cells..  85:180-194. 2016
  • Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles..  76:52-65. 2016
  • 3-Dimensional spatially organized PEG-based hydrogels for an aortic valve co-culture model..  67:354-364. 2015
  • Enhanced therapeutic neovascularization by CD31-expressing cells and embryonic stem cell-derived endothelial cells engineered with chitosan hydrogel containing VEGF-releasing microtubes..  63:158-167. 2015
  • Dynamic control and quantification of bacterial population dynamics in droplets..  61:239-245. 2015
  • Protease-degradable PEG-maleimide coating with on-demand release of IL-1Ra to improve tissue response to neural electrodes..  44:55-70. 2015
  • Microchannel-based regenerative scaffold for chronic peripheral nerve interfacing in amputees..  41:151-165. 2015
  • Macrophage embedded fibrin gels: an in vitro platform for assessing inflammation effects on implantable glucose sensors..  35:9563-9572. 2014
  • Roles of adherent myogenic cells and dynamic culture in engineered muscle function and maintenance of satellite cells..  35:9438-9446. 2014
  • Nanoparticle delivery of donor antigens for transplant tolerance in allogeneic islet transplantation..  35:8887-8894. 2014
  • The effect of inflammatory cell-derived MCP-1 loss on neuronal survival during chronic neuroinflammation..  35:6698-6706. 2014
  • A comparison of neuroinflammation to implanted microelectrodes in rat and mouse models..  35:5637-5646. 2014
  • Tissue-engineered cartilage with inducible and tunable immunomodulatory properties..  35:5921-5931. 2014
  • Robust T-tubulation and maturation of cardiomyocytes using tissue-engineered epicardial mimetics..  35:3819-3828. 2014
  • Non-viral DNA delivery from porous hyaluronic acid hydrogels in mice..  35:825-835. 2014
  • Relationship between intracortical electrode design and chronic recording function..  34:8061-8074. 2013
  • The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation..  34:8776-8785. 2013
  • The impact of chronic blood-brain barrier breach on intracortical electrode function..  34:4703-4713. 2013
  • Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes..  34:5813-5820. 2013
  • A programmable microenvironment for cellular studies via microfluidics-generated double emulsions..  34:4564-4572. 2013
  • Maintaining functional islets through encapsulation in an injectable saccharide-peptide hydrogel..  34:3984-3991. 2013
  • The modulation of MSC integrin expression by RGD presentation..  34:3938-3947. 2013
  • Effect of modulating macrophage phenotype on peripheral nerve repair..  33:8793-8801. 2012
  • Self-assembled peptide nanofibers raising durable antibody responses against a malaria epitope..  33:6476-6484. 2012
  • The upregulation of specific interleukin (IL) receptor antagonists and paradoxical enhancement of neuronal apoptosis due to electrode induced strain and brain micromotion..  33:5983-5996. 2012
  • Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function..  32:9180-9187. 2011
  • The effect of vascular endothelial growth factor (VEGF) presentation within fibrin matrices on endothelial cell branching..  32:7432-7443. 2011
  • The promotion of microvasculature formation in poly(ethylene glycol) diacrylate hydrogels by an immobilized VEGF-mimetic peptide..  32:5782-5789. 2011
  • Evolving the use of peptides as components of biomaterials..  32:4198-4204. 2011
  • Role of fibronectin in topographical guidance of neurite extension on electrospun fibers..  32:3958-3968. 2011
  • The role of extracellular matrix composition in structure and function of bioengineered skeletal muscle..  32:3575-3583. 2011
  • The spreading, migration and proliferation of mouse mesenchymal stem cells cultured inside hyaluronic acid hydrogels..  32:39-47. 2011
  • The use of micropatterning to control smooth muscle myosin heavy chain expression and limit the response to transforming growth factor β1 in vascular smooth muscle cells..  32:410-418. 2011
  • Incorporation of active DNA/cationic polymer polyplexes into hydrogel scaffolds..  31:9106-9116. 2010
  • Immune responses to coiled coil supramolecular biomaterials..  31:8475-8483. 2010
  • Protease degradable tethers for controlled and cell-mediated release of nanoparticles in 2- and 3-dimensions..  31:8072-8080. 2010
  • The dependence of MG63 osteoblast responses to (meth)acrylate-based networks on chemical structure and stiffness..  31:6131-6141. 2010
  • Multilayer microfluidic PEGDA hydrogels..  31:5491-5497. 2010
  • Biomimetic hydrogels with pro-angiogenic properties..  31:3840-3847. 2010
  • The phosphorylation of vascular endothelial growth factor receptor-2 (VEGFR-2) by engineered surfaces with electrostatically or covalently immobilized VEGF..  30:4618-4628. 2009
  • Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors..  30:3986-3995. 2009
  • Thin-film enhanced nerve guidance channels for peripheral nerve repair..  30:3834-3846. 2009
  • Nanoparticle-mediated local delivery of Methylprednisolone after spinal cord injury..  30:2582-2590. 2009
  • Biomimetic strategies based on viruses and bacteria for the development of immune evasive biomaterials..  30:1989-2005. 2009
  • Co-assembling peptides as defined matrices for endothelial cells..  30:2400-2410. 2009
  • Engineered skeletal muscle tissue networks with controllable architecture..  30:1401-1412. 2009
  • DNA delivery from matrix metalloproteinase degradable poly(ethylene glycol) hydrogels to mouse cloned mesenchymal stem cells..  30:254-265. 2009
  • Multifunctional nanocarriers for mammographic quantification of tumor dosing and prognosis of breast cancer therapy..  29:4815-4822. 2008
  • The role of aligned polymer fiber-based constructs in the bridging of long peripheral nerve gaps..  29:3117-3127. 2008
  • Three-dimensional micropatterning of bioactive hydrogels via two-photon laser scanning photolithography for guided 3D cell migration..  29:2962-2968. 2008
  • Modulating the mechanical properties of self-assembled peptide hydrogels via native chemical ligation..  29:2143-2151. 2008
  • Spatial distribution and acute anti-inflammatory effects of Methylprednisolone after sustained local delivery to the contused spinal cord..  29:1967-1975. 2008
  • Differences between the effect of anisotropic and isotropic laminin and nerve growth factor presenting scaffolds on nerve regeneration across long peripheral nerve gaps..  29:33-46. 2008
  • The effect of enzymatically degradable poly(ethylene glycol) hydrogels on smooth muscle cell phenotype..  29:314-326. 2008
  • Biomaterial-mediated retroviral gene transfer using self-assembled monolayers..  28:5121-5127. 2007
  • Epithelialization of hydrogels achieved by amine functionalization and co-culture with stromal cells..  28:5319-5331. 2007
  • Reduced foreign body response at nitric oxide-releasing subcutaneous implants..  28:4571-4580. 2007
  • Response of monocytes exposed to phagocytosable particles and discs of comparable surface roughness..  28:4231-4239. 2007
  • In vitro, in vivo and post explantation testing of glucose-detecting biosensors: current methods and recommendations..  28:3687-3703. 2007
  • The use of mild trypsinization conditions in the detachment of endothelial cells to promote subsequent endothelialization on synthetic surfaces..  28:3928-3935. 2007
  • Regulation of axon guidance and extension by three-dimensional constraints..  28:3398-3407. 2007
  • The effect of covalently immobilized rhIL-1ra-ELP fusion protein on the inflammatory profile of LPS-stimulated human monocytes..  28:3369-3377. 2007
  • Poly(ethylene glycol) hydrogels conjugated with a collagenase-sensitive fluorogenic substrate to visualize collagenase activity during three-dimensional cell migration..  28:3163-3170. 2007
  • Unconstrained recovery characterization of shape-memory polymer networks for cardiovascular applications..  28:2255-2263. 2007
  • Adult adipose-derived stem cell attachment to biomaterials..  28:936-946. 2007
  • Polylysine-functionalised thermoresponsive chitosan hydrogel for neural tissue engineering..  28:441-449. 2007
  • Virus-based gene therapy strategies for bone regeneration..  28:211-229. 2007
  • Enhanced chondrogenic differentiation of murine embryonic stem cells in hydrogels with glucosamine..  27:6015-6023. 2006
  • In vitro model of glial scarring around neuroelectrodes chronically implanted in the CNS..  27:5368-5376. 2006
  • Peripheral nerve regeneration: an opinion on channels, scaffolds and anisotropy..  27:3515-3518. 2006
  • Photolithographic patterning of polyethylene glycol hydrogels..  27:2519-2524. 2006
  • Controlled release of heparin from poly(epsilon-caprolactone) electrospun fibers..  27:2042-2050. 2006
  • Epitope tagging for tracking elastin-like polypeptides..  27:1930-1935. 2006
  • Patterning cells in highly deformable microstructures: effect of plastic deformation of substrate on cellular phenotype and gene expression..  27:1444-1451. 2006
  • Chondrocytic differentiation of human adipose-derived adult stem cells in elastin-like polypeptide..  27:91-99. 2006
  • In situ gelling hydrogels for conformal repair of spinal cord defects, and local delivery of BDNF after spinal cord injury..  27:497-504. 2006
  • Inhibition of implant-associated infections via nitric oxide release..  26:6984-6990. 2005
  • Mylar (TM) and Teflon-AF (TM) as cell culture substrates for studying endothelial cell adhesion.  26:6887-6896. 2005
  • Mylar and Teflon-AF as cell culture substrates for studying endothelial cell adhesion..  26:6887-6896. 2005
  • Nano-C60 cytotoxicity is due to lipid peroxidation..  26:7587-7595. 2005
  • A system for the direct co-culture of endothelium on smooth muscle cells..  26:4642-4653. 2005
  • Myoblast proliferation and differentiation on fibronectin-coated self assembled monolayers presenting different surface chemistries..  26:4523-4531. 2005
  • Covalently immobilized gradients of bFGF on hydrogel scaffolds for directed cell migration..  26:3227-3234. 2005
  • In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings..  26:3285-3297. 2005
  • Nanoscale neuro-integrative coatings for neural implants..  26:2983-2990. 2005
  • DNA delivery from hyaluronic acid-collagen hydrogels via a substrate-mediated approach..  26:1575-1584. 2005
  • Protein array method for assessing in vitro biomaterial-induced cytokine expression..  26:1081-1085. 2005
  • Crosslinked hyaluronic acid hydrogels: a strategy to functionalize and pattern..  26:359-371. 2005
  • Cytoprotection of PEG-modified adult porcine pancreatic islets for improved xenotransplantation..  26:403-412. 2005
  • Bioadhesive characterization of poly(methylidene malonate 2.12) microparticle on model extracellular matrix..  25:4327-4332. 2004
  • Controlled release of ethacrynic acid from poly(lactide-co-glycolide) films for glaucoma treatment..  25:4279-4285. 2004
  • Effect of streptavidin-biotin on endothelial vasoregulation and leukocyte adhesion..  25:3951-3961. 2004
  • Culture of hepatocytes on fructose-modified chitosan scaffolds..  24:2317-2322. 2003
  • Effect of streptavidin affinity mutants on the integrin-independent adhesion of biotinylated endothelial cells..  24:559-570. 2003
  • Photocrosslinkable polyvinyl alcohol hydrogels that can be modified with cell adhesion peptides for use in tissue engineering..  23:4325-4332. 2002
  • Photopolymerizable hydrogels for tissue engineering applications..  23:4307-4314. 2002
  • Glycophase glass revisited: protein adsorption and cell growth on glass surfaces bearing immobilized glycerol monosaccharides..  23:3347-3357. 2002
  • Al-Cu-Fe quasicrystal/ultra-high molecular weight polyethylene composites as biomaterials for acetabular cup prosthetics..  23:1761-1768. 2002
  • Smooth muscle cell growth in photopolymerized hydrogels with cell adhesive and proteolytically degradable domains: synthetic ECM analogs for tissue engineering..  22:3045-3051. 2001
  • Agarose gel stiffness determines rate of DRG neurite extension in 3D cultures..  22:1077-1084. 2001
  • Tethered-TGF-beta increases extracellular matrix production of vascular smooth muscle cells..  22:439-444. 2001
  • Biomaterials: Preface.  21:2213. 2000
  • Nitric oxide-generating polymers reduce platelet adhesion and smooth muscle cell proliferation..  21:2273-2278. 2000
  • An equilibrium model of endothelial cell adhesion via integrin-dependent and integrin-independent ligands..  20:2395-2403. 1999
  • Modification of surfaces with cell adhesion peptides alters extracellular matrix deposition..  20:2281-2286. 1999
  • Platelet adhesion on a bioresorbable poly(propylene fumarate-co-ethylene glycol) copolymer..  20:683-690. 1999
  • Protein patterning..  19:595-609. 1998
  • Application of total internal reflection fluorescence microscopy to study cell adhesion to biomaterials..  19:307-325. 1998
  • Planar integrated optical methods for examining thin films and their surface adlayers..  19:341-355. 1998
  • Comparison of covalently and physically cross-linked polyethylene glycol-based hydrogels for the prevention of postoperative adhesions in a rat model..  16:1153-1156. 1995
  • Polyimides as biomaterials: preliminary biocompatibility testing..  14:627-635. 1993
  • Relationship between 3T3 cell spreading and the strength of adhesion on glass and silane surfaces..  14:243-254. 1993
  • Evaluation of poly(L-lactic acid) as a material for intravascular polymeric stents..  13:176-182. 1992
  • Improved nerve regeneration through piezoelectric vinylidenefluoride-trifluoroethylene copolymer guidance channels..  12:775-780. 1991